At a Glance
- Corporate law: After eight years practicing law at Ater Wynne, Jim resigned from the Partnership to pursue business endeavors in roles of business development and later as CEO
- Partner, VP, EVP, CEO, chairman and board member
- Direct hand in structuring, formation, capital raising and M&A transactions
- Held strategic and operational positions in telecom, microbrewing, light metals production, medical devices and IoT
Key Leadership Accomplishments
- Led the financing, leasing, build out and production of FDA 501(k) medical device, all in eight months
- Transformed an Icelandic sheep pasture into a low-cost, highly efficient, low emissions highly profitable aluminum smelter
James (Jim) Hensel has 30 years of experience both inside and outside of private equity, as an attorney, CEO and director. Jim successfully builds and transitions organizations throughout the business lifecycle from incubation/startup through M&A to liquidity/succession. He has served as CEO in several telecommunications, high-technology and medical device companies, including Thermogen Technologies, a developer of an Internet of Things (IoT) energy harvesting device, Metro One Telecommunications, a provider of enhanced telecommunication services, and HemCon Medical Technologies, a medical device innovator of a hemorrhage control bandage. In addition to board roles with all of these organizations, Jim served on several other boards, including Saladax Biomedical, where he served as chair of the Compensation Committee and served on the Executive Committee, Pivotel Group, Hibernia Atlantic (now GTT Communications), Magnet Networks, Nordural, and the non-profit Oregon Food Bank.
Jim holds a Bachelor of Arts in Economics from Harvard University and a Juris Doctor from the Willamette University College of Law.